NCT04079595
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +21 more
- Locations
-
- Department of Radiation Oncology Zurich, Switzerland
Clinical trial condition
Meningioma
Explore clinical trials studying Meningioma. Study availability and eligibility vary by location and protocol.
186 public trials
62 recruiting studies
Meningioma trial results
NCT00019630
- Conditions
- Adenocarcinoma, Astrocytoma, Bone Cancer, +85 more
- Locations
-
- Pediatric Oncology Branch Bethesda, Maryland, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
NCT06180226
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +7 more
- Locations
-
Not specified
NCT05537675
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +8 more
- Locations
-
- Nuclear medicine Department CHRU de NANCY Vandœuvre-lès-Nancy, France
NCT00019578
- Conditions
- Adult Brain Stem Glioma, Adult Central Nervous System Germ Cell Tumor, Adult Craniopharyngioma, +42 more
- Locations
-
- Radiation Oncology Branch Bethesda, Maryland, United States
NCT00895622
- Conditions
- Brain Diseases, Brain Neoplasms, Brain and Central Nervous System Tumors, +11 more
- Locations
-
- Arizona Oncology Services Foundation Phoenix, Arizona, United States
- Mayo Clinic Hospital Phoenix, Arizona, United States
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
NCT04478877
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +7 more
- Locations
-
- Department of Surgery, The Chinese University of Hong Kong Hong Kong
NCT03953131
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02333565
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +9 more
- Locations
-
- Assistance Publique Hôpitaux Marseille Marseille, France
Completed
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)
NCT03273712
- Conditions
- Central Nervous System Neoplasms, Glioma, Medulloblastoma, +17 more
- Locations
-
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States